Search - tctmd.com

Displaying 81 - 100 of 433

Sort: Relevancy | Date

Presentation TCT 2021

Limitations of TEER and Justification for Additional Transcatheter Repair Concepts

Presenter: Georg Nickenig

November 05, 2021

Presentation TCT 2021

AorticLab GEMINI - Functional Recovery of Stenotic Aortic Valve With A Double Ultrasound Wave Effect

Presenter: Federico De Marco

November 05, 2021

Presentation TCT 2021

Longer-term Concerns: What Comes Next?

Presenter: Tsuyoshi Kaneko

November 05, 2021

Presentation TCT 2021

First Dedicated Transcatheter Leaflet Splitting Device From Bench to FIH (ShortCut)

Presenter: Susheel Kodali

November 05, 2021

Presentation TCT 2021

DurAVR THV: A Novel 3D Single Piece Valve Designed for Improved Durability and Hemodynamics

Presenter: Samir Kapadia

November 05, 2021

Presentation TCT 2021

Short-term Priorities: Optimal Intervention for the Patient With Longer Life Expectancy

Presenter: Amar Krishnaswamy

November 05, 2021

Presentation TCT 2021

A Pressure Wire for Valve Implantation and Continuous Hemodynamic Monitoring During TAVR Procedures: Initial Experience with the SavvyWire

Presenter: Josep Rodés-Cabau

November 05, 2021

Presentation TCT 2021

Evaluation of the OpSens OptoWire III and its Novel TAVR Algorithm to Measure Pressure Gradient before and After TAVR Compared With Hemodynamic Value Derived by Catheterization and Echocardiogram

Presenter: Philippe Genereux

November 05, 2021

Presentation TCT 2021

The Journey in Clinical Context (Case Presentation)

Presenter: Itsik Ben-Dor

November 05, 2021

Presentation TCT 2021

Innovation in the TAVR Space: Remaining Challenges and Opportunities

Presenter: Eberhard Grube

November 05, 2021

Presentation TCT 2021

Left Atrial Appendage Interventions – Closing the Key Evidence Gaps to Move the Field Forward, From FDA Perspective

Presenter: Kan Fang

November 05, 2021

Presentation TCT 2021

AMULET IDE: One-Year Device Closure From a Randomized Trial of Amulet Versus Watchman for Left Atrial Appendage Occlusion

Presenter: Dhanunjaya Lakkireddy

November 05, 2021

Presentation TCT 2021

Tricuspid Valve Interventions - Adding Quality of Life to Years, from Industry Perspective

Presenter: Suzanne Arnold

November 05, 2021

News Conference News TCT 2021

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Michael O'Riordan

November 05, 2021

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

Presentation TCT 2021

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Presenter: Nicolas Van Mieghem

November 05, 2021

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

Presentation TCT 2021

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Presenter: Ori Ben-Yehuda

November 05, 2021

Presentation TCT 2021

Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk

Presenter: Joanna Chikwe

November 05, 2021

Advertisement

Limitations of TEER and Justification for Additional Transcatheter Repair Concepts

AorticLab GEMINI - Functional Recovery of Stenotic Aortic Valve With A Double Ultrasound Wave Effect

Longer-term Concerns: What Comes Next?

First Dedicated Transcatheter Leaflet Splitting Device From Bench to FIH (ShortCut)

DurAVR THV: A Novel 3D Single Piece Valve Designed for Improved Durability and Hemodynamics

Short-term Priorities: Optimal Intervention for the Patient With Longer Life Expectancy

A Pressure Wire for Valve Implantation and Continuous Hemodynamic Monitoring During TAVR Procedures: Initial Experience with the SavvyWire

Evaluation of the OpSens OptoWire III and its Novel TAVR Algorithm to Measure Pressure Gradient before and After TAVR Compared With Hemodynamic Value Derived by Catheterization and Echocardiogram

The Journey in Clinical Context (Case Presentation)

Innovation in the TAVR Space: Remaining Challenges and Opportunities

Left Atrial Appendage Interventions – Closing the Key Evidence Gaps to Move the Field Forward, From FDA Perspective

AMULET IDE: One-Year Device Closure From a Randomized Trial of Amulet Versus Watchman for Left Atrial Appendage Occlusion

Tricuspid Valve Interventions - Adding Quality of Life to Years, from Industry Perspective

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content